NCT04060732View on ClinicalTrials.gov

"Feasibility and Safety of Flash Glucose Monitoring-FGM in an Adult Italian Population."

CompletedOBSERVATIONAL
Enrollment

350

Participants

Timeline

Start Date

May 5, 2017

Primary Completion Date

January 31, 2020

Study Completion Date

December 30, 2020

Conditions
Diabetes Mellitus, Type 1
Interventions
DEVICE

Flash Glucose Monitoring-FGM

"The Flash Glucose Monitoring-FGM is a real-time glycemic monitoring system called hybrid will be assigned to the enrolled patients at baseline until the end of follow-up after 12 months."

Trial Locations (1)

43100

Azienda Ospedaliero Universitaria, Parma

All Listed Sponsors
collaborator

Regione Emilia-Romagna

OTHER

lead

Azienda Ospedaliero-Universitaria di Parma

OTHER

NCT04060732 - "Feasibility and Safety of Flash Glucose Monitoring-FGM in an Adult Italian Population." | Biotech Hunter | Biotech Hunter